Rare Disease Communities beta
- Sign in
- Register
-
- Visit a community
- Alkaptonuria (AKU)
- Alternating Hemiplegia
- Atypical Hemolytic Uremic Syn.
- Behçet’s Syndrome
- CAPS
- CDG
- Cystinosis
- Dravet syndrome
- Ehlers-Danlos syndrome (EDS)
- Epidermolysis Bullosa
- Familial Mediterranean Fever
- Glut1 DS
- Hereditary Spastic Paraplegia
- Waldenstrom macroglobulinemia
- Multiple Myeloma
- Moebius syndrome
- Paraneoplastic Neurological Syn.
- Von Hippel-Lindau
Meet, discuss & support other patients or families living with CAPS . Participate in group discussions. Contribute to topics, or just share what's on your mind
Conversations
View: Translations (EN) Original language[ Expand all ]
-
karend | published 4 days ago | Originally written in English Great Article about a family with FCAS
This is a nice article about a family with FCAS that includes some in the UK and the US. www.grandforksherald.com/event/article/id/...
-
robpleticha | Medication, NOMID | published 9 days ago | Originally written in English Drug halts organ damage in inflammatory genetic disorder
National Institutes of Health study suggests Kineret effective treatment for NOMID/CINCA
-
ambern | published 10 days ago | Originally written in English Son recently Dx with Muckle Wells Syndrome
Hi, My name is Amber, I have a 4yr old that has just been dx with muckle wells. I am so blessed to have found Dr. Lowe in Birmingham,AL. Until now I felt like it was a uphill battle to get answers for my son. He started out with ezcema as a infant and we noticed it happened when we went back to Ky to visit family. He would often get mouth ulcers and have unexplained fevers and was hospitalized twice for this. Dr.'s acted as if it was always a random virus that they just couldn't explain. I noticed his pattern of mouth ulcers, fevers, rash, and joint pain and when I brought these symptoms up to his regular physician he looked at me like I was a nut. Even my husband wasn't understanding our sons battle with itching and knee pain. I was told Kids just get these things and since it goes away don't worry. I am very determined at this point and continued to take him back to the Dr. everytime these symptoms would arise. Finally he refered us to a pediatric Rheumatologist in Birmingham Al. We were there for several vists when he had no symptoms. This past Friday his Dr. met me in his office although he wasn't in clinic that day and after looking at his visible rash and red eyes, joint swelling, he said he has Muckle Wells. He had told me he thought that before and we had already had the genetic test done to see if he has the mutation but we are still waiting on results. Reading this forum I couldn't help but cry.Which sounds silly but just knowing that there are others I finally felt like there are people who understand. There is a lot of relief knowing your not alone.
-
Yufan published 8 days ago | Originally written in EnglishDear Karen:
Thanks, that's a big help. I will go to check it out and bring it to my doctor.
Yufan :)
-
ambern published 8 days ago | Originally written in EnglishI am sorry you are having trouble Yufan, I hope that your daughter gets approved soon! We got the news last night that my son was approved and we get our first batch on Friday. Yufan you were on my mind last night , I will be praying for approval for your daughter! Much love and thoughts your way!!
Amber
256-520-7168 -
Yufan published 8 days ago | Originally written in EnglishI am so happy for you. The nurse said we should get the answer from insurance company at the end of this week. I plan to call them again around thursday if I didn't heard from them.
After reading Paul's message, I felt much better. Seems with the treatment, they still can have a pretty normal life.
Good Luck to all of us.
-
-
Yufan | Treatment & Care | published about 1 month ago | Originally written in English MWS and Canakinumab
My daughter just be diagnosed as MWS 2 days ago. She has serious inflammation on the day she was born. We have been to different doctors and specialists since she is a baby. Now she is 8, has pseudo tumor cerebri, hearing loss, and all other symptoms of MWS. She will begin her treatment 2 weeks later. Her doctor said she is the first case here at the Children hospital. It kind of makes me nervous about the treatment.
I am still kind of lost here about the disease information and how is the cost of the treatment. Will insurance cover this treatment? I read a article about the cost of Canakinum is 100,000 a year???
Also any long term effect on this drug?
I have read some posts. Really helpful. Thanks for those who share their experience. It's let me feel we are not the only one here.-
karend published 29 days ago | Originally written in EnglishYou are very welcome! Please do not hesitate to contact me for anything. We are here to help.
Karen Durrant
-
paul published 9 days ago | Originally written in FrenchBonjour Yufan,
unfortunately, I can see that the message that I posted about 2 weeks ago on this forum is not showing. too bad !
Has your daughter started her treatment?
don't worry about the treatment, it's proven itself on adults as well as children.
Right now, a follow-up on young patients (younger than two) in our association is very positive for canakinumab.in our family ten of us are being treated, either with anakinra (kineret) ou canakinumab (ilaris) and we have a good tolerance for the shots without side effects.
for my two young children who are almost your daughter's age, treated with kineret, the daily shot, which was a little bit difficult at the beginning, is no longer a problem.
to avoid pain, there are anti-pain patches
one of our younger children no longer wants the patch, it is indeed constraining since you have to use it one hour before the shot.
regarding hearing loss, one of our younger children has a hearing aid to go to school. Apres a year of treatment, he no longer uses her hearing aids. So you can have hope.
For your doctor who is seeing his first case in his hospital, it is important to know that the medical community understands CAPS well now. During an international conference in Amsterdam, at which a representative of Nomidalliance was present with me and my wife, we could see that there were a lot of exchanges between associations of patients and doctors of the entire world. Publications are regularly updates on pubmed (in English)
I noticed the same thing during a meeting organized in Barcelona (Spain) by Denis Costello who manages communities within Eurordis. During the visit in the hospital facility, the Spanish doctors showed us that they constantly communicate with their French colleagues and also with other world specialists.
the cost of canakinum (ilaris) is very high: in France, 12.000 euros per shot every 8 weeks. It is very well covered by our public health system.
unfortunately, it is not the case in Switzerland, Germany, Belgium, Russia et also where you live in the US.
This is unfortunately the information gives by families who were contacted by our association AMWS-CINCA (www.amws-cinca.eu)You are lucky that you can count on Karen, whom I know well as we met in France last July - see the community report under the heading UNDERSTANDING and the title Fifth Anniversary. It was a very enriching meeting.
To be read
sincerely Paul President AMWS-CINCA (France)
Notice: This text content has been translated automatically by a third-party service.
-
Yufan published 8 days ago | Originally written in EnglishDear Paul:
Thanks for your message. The most fear I had when I got the news was that I could not see my daughter grow up. After reading your message I feel much better. I can see she still can have a normal happy life in the future.
Thank you very much !!!
-
CAPS community news
-
Drug halts organ damage in inflammatory genetic disorder
show transcript
News, published 10 days ago
NIH study shows benefits of long-term Kineret therapy in people with NOMID -
Cuts in Ireland drastically impacting young man with CINCA's future
show transcript
News, published 5 months ago
Aisling McNiffe's voice crackles when she talks about her son's school prospects. Jack, a chirpy, fair-haired six-year old with a fondness for Toy Story movies, is the only person in the world known to have both Down's Syndrome and CINCA Syndrome, a degenerative disease that causes crippling headaches, severe arthritis, skin rashes, deafness and blindness. -
Clinical Outcomes and Safety: A Registry Study of Ilaris (Canakinumab) Patients
show transcript
News, published 7 months ago
The purpose of this observational study is to collect additional information regarding long-term safety and effectiveness of Ilaris in the treatment of CAPS patients in clinical practice. -
Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease
show transcript
News, published 9 months ago
This study will evaluate the safety and effectiveness of anakinra (Kineret(Registered Trademark)) for treating patients with neonatal onset multisystem inflammatory disease (NOMID), also known as chronic infantile neurological, cutaneous and arthropathy (CINCA) syndrome. -
From the Australian Prescriber: New drugs Canukinumab
show transcript
News, published 11 months ago
CanakinumabSome of the views expressed in the following notes on newly approved products should be regarded as tentative, as there may have been limited published data and little experience in Australia of their safety or efficacy. However, the Editorial Executive Committee believes that comments made in good faith at an early stage may still be of value. As a result of fuller experience, initial comments may need to be modified. The Committee is prepared to do this. Before new drugs are prescribed, the Committee believes it is important that full information is obtained either from the manufacturer's approved product information, a drug information centre or some other appropriate source.
(Aust Prescr 2011;34:55-9)
Ilaris (Novartis)
vials containing 150 mg lyophilised powder for reconstitution
Approved indication: cryopyrin-associated periodic syndromes
Australian Medicines Handbook section 15.2.2 -
Más calidad de vida con biológicos en niños con patologías autoinflamatorias
show transcript
News, published 11 months ago
En el segundo gran grupo, el del síndrome de la fiebre persistente, no mantienen estos episodios tan marcados. Aquí se ubica el síndrome de CAPS o criopirinopatías. Las criopirinas son las proteínas que ponen en marcha el mecanismo inflamatorio. -
“Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID/CAPS, DIRA, CRMO, Still's Disease, Behcet's Disease, and Other Undifferentiated Autoinflammatory Diseases)”
show transcript
News, published 12 months ago
Overall Status: RecruitingThis study will examine and test patients with neonatal onset multi-system inflammatory disease (NOMID) to learn more about the cause and course of the disease. It will study the disease signs and symptoms and the possible role of a gene called CIAS1, and it will develop a database to gather information on patients with NOMID in the United States and around the world. It will also serve as a screening protocol to offer eligible patients participation in a treatment protocol, if an appropriate one is available.
-
NOMID in the news in Canada
show transcript
News, published about 1 year ago
Such is the case for seven-year-old Brampton resident Michael Spiridakis, who suffers from neonatal onset multisystem inflammatory disease (NOMID), a genetic disorder that causes uncontrolled inflammation in multiple parts of the body. -
Wood River teen pushes recognition of rare diseases
show transcript
News, published about 1 year ago
Radney, 16, has a particular interest in the subject of rare diseases because almost four years ago she discovered she has Neonatal Onset Multisystem Inflammatory Disease, also called NOMID..... -
Four cases of Muckle-Wells syndrome within the same family
show transcript
News, published about 1 year ago
ABSTRACTMuckle-Wells syndrome is a rare autosomal dominant disease that belongs to a group of hereditary febrile syndromes. It is characterized by recurrent and self-limited episodes of fever, urticaria, arthralgia, myalgia and conjunctivitis since childhood, which are related to exposure to cold temperatures. Lately, progressive sensorineural hearing loss occurs. Amyloidosis is the main complication and can be found in about 25% of the cases. It has been demonstrated that there is an association with mutations in the NLRP3 gene, which codifies cryopyrin, a protein responsible for regulating the production of proinflammatory cytokines, such as interleukin-1Beta. The authors report four cases of the disease within a family.